The Rapatriement des cerveaux Program was launched in 2007 by the Institut du cancer de Montréal during a major campaign organized as part of the 60th anniversary of its founding. During this campaign, a net amount of $1.2 million was raised.

This program helps to counter the exodus of researchers, a phenomenon that threatens scientific progress in cancer research and the influence of Montreal researchers. With these funds, the Institute facilitates the return of researchers to Montreal by providing them with $250,000 in start-up funds to support them during their first five years. To date, it has helped 11 top researchers return to the CHUM Research Centre, set up their laboratories and build their research teams.

The 11 researchers repatriated through this program are :

Dr. Marie-Claude Bourgeois-Daigneault received her PhD from the Université de Montréal in 2012. She was repatriated in 2018 from the Ottawa Hospital Research Institute in Ontario. She specializes in cancer viral therapy and cancer vaccination. View her researcher sheet here.
Dr. Bertrand Routy received his PhD in 2017 from the University of Paris XI (Paris-Sud). He was repatriated from the Institut Gustave Roussy of the University of Paris XI (Paris-Sud) in 2018. He specializes in hemato-oncology. View his researcher sheet here.
Dr. Saima Hassan received her PhD in Experimental Surgery from McGill University in 2009, after graduating from the Faculty of Medicine. Repatriated in 2016 from Oregon Health and Science University, Oregon, USA, Dr. Hassan focuses on the role of PARP inhibitors for patients with triple-negative breast cancer. View her researcher sheet here.
Dr. Philip Wong graduated from McGill University in 2010 with a degree in radiation oncology. He was repatriated in 2014 from the CIHR Terry Fox Foundation, Toronto. He specializes in translational research on radiation therapy and sarcoma.
Dr. Simon Turcotte received his medical degree in 2003 and his master’s degree in 2008 in biomedical sciences from the Université de Montréal. He was repatriated in 2013 from Memorial Sloan-Kettering Cancer Center, New York, USA. He specializes in immune recognition of gastrointestinal cancers. View his researcher sheet here.
Dr. Dominique Trudel received her PhD in 2014 from Laval University. She was repatriated in 2013 from the University Health Network, Toronto. She specializes in the diagnostic and prognostic application of tissue and optical markers in prostate cancers. View her researcher sheet here.
Dr. John Stagg received his PhD from McGill University. He was repatriated in 2010 from the Peter MacCallum Cancer Centre, Melbourne, Australia. He specializes in the development of targeted cancer therapies based on the stimulation of the anti-tumor immune response. View his researcher sheet here.
Dr. Francis Rodier received his PhD in 2005 from the Université de Montréal and was repatriated in 2009 from the Buck Institute for Research on Aging, California, USA. He specializes in exploring the cross-relationship between cellular senescence, aging and cancer. View his researcher sheet here.
Dr. Jean-François Cailhier did his medical training at the Université de Montréal and his PhD at the University of Edinburgh, UK. He was repatriated in 2008 and specializes in evaluating the role of inflammatory and neoplastic microenvironments in macrophage reprogramming. View his researcher sheet here.
Dr. Jean Baptiste Lattouf received his medical degree in 1999 from the Université de Montréal. He was repatriated in 2008 after completing his post-doctoral fellowship at the National Institutes of Health, Maryland, USA. He specializes in immunology, molecular biology and biomarkers in kidney cancer. View his researcher sheet here.
Dr. Estelle Schmitt received her PhD from the Université de Montréal. She was repatriated in 2008 from the Université Paul Sabatier, Toulouse, France. She specializes in epithelial ovarian cancer.